Agomab Therapeutics NV
NASDAQ:AGMB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Agomab Therapeutics NV
NASDAQ:AGMB
|
BE |
|
C
|
Coromandel Engineering Company Ltd
BSE:533167
|
IN |
|
G
|
Greiffenberger AG
XBER:GRF
|
DE |
|
E
|
Ethos Gold Corp
F:1ET
|
CA |
|
C
|
Click To Raffle.Com Inc
OTC:AQFD
|
US |
Bankruptcy Probability
Agomab Therapeutics NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Agomab Therapeutics NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BE |
A
|
Agomab Therapeutics NV
NASDAQ:AGMB
|
648.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
M
|
Metsera Inc
NASDAQ:MTSR
|
7.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
S
|
Samsung Epis Holdings Co Ltd
KRX:0126Z0
|
9.4T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Oruka Therapeutics Inc
NASDAQ:ORKA
|
5.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Definium Therapeutics Inc
NASDAQ:DFTX
|
5.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
P
|
Parabilis Medicines Inc
NASDAQ:PBLS
|
4.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
BillionToOne Inc
NASDAQ:BLLN
|
4.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
V
|
Veradermics Inc
NYSE:MANE
|
4.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Grail Inc
NASDAQ:GRAL
|
3.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| TW |
|
Pell Bio Med Technology Co Ltd
TWSE:6949
|
96.9B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IN |
|
Rubicon Research Ltd
NSE:RUBICON
|
281.4B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Agomab Therapeutics NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Agomab Therapeutics NV has total debt of 1m . This includes both short-term (0 ) and long-term (1m ) debt.
You can find a full breakdown on its Balance Sheet.
